Efficacy and Safety of Eculizumab in Refractory Myasthenia Gravis: A Meta-analysis and Systematic Review (P7-11.033)
This study evaluates the efficacy and safety of long-term use of eculizumab for refractory Myasthenia Gravis (MG).
Authors
- Sristee Niraula
- Ali Elbagir Ali Mohamed
- Hiba Omer (ORCID: https://orcid.org/0000-0002-1501-1760)
- Muhammad Butt (ORCID: https://orcid.org/0000-0001-7920-3668)
- Ayesha Azhar (ORCID: https://orcid.org/0000-0002-8123-7020)
- Alexander Amir (ORCID: https://orcid.org/0000-0003-0967-3714)
- Azka Ijaz
- Alieu Kanu (ORCID: https://orcid.org/0000-0002-4140-4875)
- Aishwarya Koppanatham (ORCID: https://orcid.org/0009-0000-5737-4474)
- Eisha Moazzam
- Haseeb Bin Najeeb
Institutions
- King Edward Medical University (PK)
- University of Khartoum (SD)
- University of Sierra Leone (SL)
- Allama Iqbal Medical College (PK)
- Combined Military Hospital (PK)
- Dow University of Health Sciences (PK)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211866
- Citations
- 1
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 1.39